USD 2.08
(0.48%)
Year | Total Assets | Total Assets Growth |
---|---|---|
2023 | 304.27 Million USD | -27.13% |
2022 | 417.57 Million USD | -26.99% |
2021 | 571.96 Million USD | 288.59% |
2020 | 147.19 Million USD | -10.87% |
2019 | 165.13 Million USD | -33.43% |
2018 | 248.07 Million USD | 0.0% |
Year | Total Assets | Total Assets Growth |
---|---|---|
2024 Q3 | 265.27 Million USD | -2.85% |
2024 Q1 | 284.28 Million USD | -6.57% |
2024 Q2 | 273.06 Million USD | -3.95% |
2023 Q2 | 364.58 Million USD | -4.48% |
2023 FY | 304.27 Million USD | -27.13% |
2023 Q1 | 381.68 Million USD | -8.59% |
2023 Q4 | 304.27 Million USD | -8.96% |
2023 Q3 | 334.22 Million USD | -8.33% |
2022 Q2 | 496.63 Million USD | -7.24% |
2022 Q1 | 535.42 Million USD | -6.39% |
2022 FY | 417.57 Million USD | -26.99% |
2022 Q4 | 417.57 Million USD | -5.8% |
2022 Q3 | 443.25 Million USD | -10.75% |
2021 FY | 571.96 Million USD | 288.59% |
2021 Q1 | 647.47 Million USD | 339.89% |
2021 Q4 | 571.96 Million USD | -1.44% |
2021 Q3 | 580.31 Million USD | -8.07% |
2021 Q2 | 631.26 Million USD | -2.5% |
2020 FY | 147.19 Million USD | -10.87% |
2020 Q4 | 147.19 Million USD | 13.14% |
2020 Q3 | 130.09 Million USD | 227613.98% |
2020 Q2 | 57.13 Thousand USD | 0.0% |
2020 Q1 | - USD | -100.0% |
2019 Q4 | 165.13 Million USD | 0.0% |
2019 FY | 165.13 Million USD | -33.43% |
2018 FY | 248.07 Million USD | 0.0% |
Name | Total Assets | Total Assets Difference |
---|---|---|
Abbott Laboratories | 73.21 Billion USD | 99.584% |
Allurion Technologies Inc. | 71.71 Million USD | -324.3% |
Artivion, Inc. | 792.39 Million USD | 61.601% |
Avanos Medical, Inc. | 1.69 Billion USD | 82.021% |
Butterfly Network, Inc. | 304.27 Million USD | 0.0% |
Bio-Rad Laboratories, Inc. | 12.29 Billion USD | 97.526% |
Boston Scientific Corporation | 35.13 Billion USD | 99.134% |
CONMED Corporation | 2.3 Billion USD | 86.771% |
Edwards Lifesciences Corporation | 9.36 Billion USD | 96.75% |
Paragon 28, Inc. | 340.69 Million USD | 10.691% |
Glaukos Corporation | 940.41 Million USD | 67.645% |
Globus Medical, Inc. | 5.08 Billion USD | 94.018% |
Inspire Medical Systems, Inc. | 676.81 Million USD | 55.043% |
Integer Holdings Corporation | 2.94 Billion USD | 89.66% |
Medtronic plc | 89.98 Billion USD | 99.662% |
Myomo, Inc. | 14.58 Million USD | -1986.703% |
Nevro Corp. | 635.71 Million USD | 52.137% |
Owlet, Inc. | 44.12 Million USD | -589.604% |
Penumbra, Inc. | 1.55 Billion USD | 80.449% |
Vicarious Surgical Inc. | 119.86 Million USD | -153.849% |
Smith & Nephew plc | 9.98 Billion USD | 96.953% |
Sonendo, Inc. | 78.16 Million USD | -289.296% |
STERIS plc | 11.06 Billion USD | 97.25% |
Stryker Corporation | 39.91 Billion USD | 99.238% |
Vapotherm, Inc. | 77.61 Million USD | -292.02% |
Zimmer Biomet Holdings, Inc. | 21.49 Billion USD | 98.585% |